Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2016

01-02-2016 | Commentary

Pharmacist independent prescribing in secondary care: opportunities and challenges

Authors: Richard S. Bourne, Wasim Baqir, Raliat Onatade

Published in: International Journal of Clinical Pharmacy | Issue 1/2016

Login to get access

Abstract

In recent years a number of countries have extended prescribing rights to pharmacists in a variety of formats. The latter includes independent prescribing, which is a developing area of practice for pharmacists in secondary care. Potential opportunities presented by wide scale implementation of pharmacist prescribing in secondary care include improved prescribing safety, more efficient pharmacist medication reviews, increased scope of practice with greater pharmacist integration into acute patient care pathways and enhanced professional or job satisfaction. However, notable challenges remain and these need to be acknowledged and addressed if a pharmacist prescribing is to develop sufficiently within developing healthcare systems. These barriers can be broadly categorised as lack of support (financial and time resources), medical staff acceptance and the pharmacy profession itself (adoption, implementation strategy, research resources, second pharmacist clinical check). Larger multicentre studies that investigate the contribution of hospital-based pharmacist prescribers to medicines optimisation and patient-related outcomes are still needed. Furthermore, a strategic approach from the pharmacy profession and leadership is required to ensure that pharmacist prescribers are fully integrated into future healthcare service and workforce strategies.
Literature
1.
go back to reference Emmerton L, Marriott J, Bessell T, Nissen L, Dean L. Pharmacists and prescribing rights: review of international developments. J Pharm Pharm Sci. 2005;8:217–25.PubMed Emmerton L, Marriott J, Bessell T, Nissen L, Dean L. Pharmacists and prescribing rights: review of international developments. J Pharm Pharm Sci. 2005;8:217–25.PubMed
2.
go back to reference Baqir W, Miller D, Richardson G. A brief history of pharmacist prescribing in the UK. Eur J Hosp Pharm Sci Pract. 2012;19:487–8.CrossRef Baqir W, Miller D, Richardson G. A brief history of pharmacist prescribing in the UK. Eur J Hosp Pharm Sci Pract. 2012;19:487–8.CrossRef
3.
go back to reference Yuksel N, Eberhart G, Bungard TJ. Prescribing by pharmacists in Alberta. Am J Health Syst Pharm. 2008;65:2126–32.CrossRefPubMed Yuksel N, Eberhart G, Bungard TJ. Prescribing by pharmacists in Alberta. Am J Health Syst Pharm. 2008;65:2126–32.CrossRefPubMed
6.
go back to reference Al Hamarneh YN, Charrois T, Lewanczuk R, Tsuyuki RT. Pharmacist intervention for glycaemic control in the community (the RxING study). BMJ Open. 2013;3:e003154.CrossRefPubMedPubMedCentral Al Hamarneh YN, Charrois T, Lewanczuk R, Tsuyuki RT. Pharmacist intervention for glycaemic control in the community (the RxING study). BMJ Open. 2013;3:e003154.CrossRefPubMedPubMedCentral
7.
go back to reference Houle SK, Chuck AW, McAlister FA, Tsuyuki RT. Effect of a pharmacist managed hypertension program on health system costs: an Evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN). Pharmacotherapy. 2012;32:527–37.CrossRefPubMed Houle SK, Chuck AW, McAlister FA, Tsuyuki RT. Effect of a pharmacist managed hypertension program on health system costs: an Evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN). Pharmacotherapy. 2012;32:527–37.CrossRefPubMed
8.
go back to reference McAlister FA, Majumdar SR, Padwal RS, Fradette M, Thompson A, Buck B, et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. CMAJ. 2014;186:577–84.CrossRefPubMedPubMedCentral McAlister FA, Majumdar SR, Padwal RS, Fradette M, Thompson A, Buck B, et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. CMAJ. 2014;186:577–84.CrossRefPubMedPubMedCentral
9.
go back to reference Tsuyuki R, Houle S, Charrois T, Kolber M, Rosenthal M, Lewanczuk R, et al. A randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community: the Alberta clinical trial in optimizing hypertension (RxACTION). Circulation. 2015;132:93–100.CrossRefPubMed Tsuyuki R, Houle S, Charrois T, Kolber M, Rosenthal M, Lewanczuk R, et al. A randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community: the Alberta clinical trial in optimizing hypertension (RxACTION). Circulation. 2015;132:93–100.CrossRefPubMed
12.
go back to reference Tonna AP, Stewart DC, West B, McCaig DJ. Exploring pharmacists’ perceptions of the feasibility and value of pharmacist prescribing of antimicrobials in secondary care in Scotland. Int J Pharm Pract. 2010;18:312–9.CrossRefPubMed Tonna AP, Stewart DC, West B, McCaig DJ. Exploring pharmacists’ perceptions of the feasibility and value of pharmacist prescribing of antimicrobials in secondary care in Scotland. Int J Pharm Pract. 2010;18:312–9.CrossRefPubMed
15.
go back to reference Ryan C, Ross S, Davey P, Duncan EM, Francis JJ, Fielding S, et al. Prevalence and causes of prescribing errors: the PRescribing Outcomes for Trainee doctors Engaged in Clinical Training (PROTECT) study. PLoS One. 2014;9:e79802.CrossRefPubMedPubMedCentral Ryan C, Ross S, Davey P, Duncan EM, Francis JJ, Fielding S, et al. Prevalence and causes of prescribing errors: the PRescribing Outcomes for Trainee doctors Engaged in Clinical Training (PROTECT) study. PLoS One. 2014;9:e79802.CrossRefPubMedPubMedCentral
16.
go back to reference Dean B, Schachter M, Vincent C, Barber N. Causes of prescribing errors in hospital inpatients: a prospective study. Lancet. 2002;359:1373–8.CrossRefPubMed Dean B, Schachter M, Vincent C, Barber N. Causes of prescribing errors in hospital inpatients: a prospective study. Lancet. 2002;359:1373–8.CrossRefPubMed
17.
go back to reference Ross S, Ryan C, Duncan EM, Francis JJ, Johnston M, Ker JS, et al. Perceived causes of prescribing errors by junior doctors in hospital inpatients: a study from the PROTECT programme. BMJ Qual Saf. 2013;22:97–102.CrossRefPubMed Ross S, Ryan C, Duncan EM, Francis JJ, Johnston M, Ker JS, et al. Perceived causes of prescribing errors by junior doctors in hospital inpatients: a study from the PROTECT programme. BMJ Qual Saf. 2013;22:97–102.CrossRefPubMed
19.
go back to reference Baqir W, Crehan O, Murray R, Campbell D, Copeland R. Pharmacist prescribing within a UK NHS hospital trust: nature and extent of prescribing, and prevalence of errors. Eur J Hosp Pharm Sci Pract. 2014;22:79–82.CrossRef Baqir W, Crehan O, Murray R, Campbell D, Copeland R. Pharmacist prescribing within a UK NHS hospital trust: nature and extent of prescribing, and prevalence of errors. Eur J Hosp Pharm Sci Pract. 2014;22:79–82.CrossRef
20.
go back to reference Onatade R, Al-Azeib S, Gore S. Description and evaluation of the quality of pharmacist-written discharge medication. Int J Pharm Pract. 2014;22(S2):82–83. Onatade R, Al-Azeib S, Gore S. Description and evaluation of the quality of pharmacist-written discharge medication. Int J Pharm Pract. 2014;22(S2):82–83.
21.
go back to reference Seden K, Kirkham JJ, Kennedy T, Lloyd M, James S, Mcmanus A, et al. Cross-sectional study of prescribing errors in patients admitted to nine hospitals across North West England. BMJ Open. 2013;3:e002036.CrossRefPubMedPubMedCentral Seden K, Kirkham JJ, Kennedy T, Lloyd M, James S, Mcmanus A, et al. Cross-sectional study of prescribing errors in patients admitted to nine hospitals across North West England. BMJ Open. 2013;3:e002036.CrossRefPubMedPubMedCentral
22.
go back to reference Graabæk T, Kjeldsen LJ. Medication reviews by clinical pharmacists at hospitals lead to improved patient outcomes: a systematic review. Basic Clin Pharmacol Toxicol. 2013;112:359–73.CrossRefPubMed Graabæk T, Kjeldsen LJ. Medication reviews by clinical pharmacists at hospitals lead to improved patient outcomes: a systematic review. Basic Clin Pharmacol Toxicol. 2013;112:359–73.CrossRefPubMed
23.
go back to reference Marotti SB, Kerridge RK, Grimer MD. A randomised controlled trial of pharmacist medication histories and supplementary prescribing on medication errors in postoperative medications. Anaesth Intensive Care. 2011;39:1064–70.PubMed Marotti SB, Kerridge RK, Grimer MD. A randomised controlled trial of pharmacist medication histories and supplementary prescribing on medication errors in postoperative medications. Anaesth Intensive Care. 2011;39:1064–70.PubMed
24.
go back to reference Mergenhagen KA, Blum SS, Kugler A, Livote EE, Nebeker JR, Ott MC, et al. Pharmacist- versus physician-initiated admission medication reconciliation: impact on adverse drug events. Am J Geriatr Pharmacother. 2012;10:242–50.CrossRefPubMed Mergenhagen KA, Blum SS, Kugler A, Livote EE, Nebeker JR, Ott MC, et al. Pharmacist- versus physician-initiated admission medication reconciliation: impact on adverse drug events. Am J Geriatr Pharmacother. 2012;10:242–50.CrossRefPubMed
25.
go back to reference Tonna A, Stewart D, West B, McCaig D. Pharmacist prescribing in the UK—a literature review of current practice and research. J Clin Pharm Ther. 2007;32:545–56.CrossRefPubMed Tonna A, Stewart D, West B, McCaig D. Pharmacist prescribing in the UK—a literature review of current practice and research. J Clin Pharm Ther. 2007;32:545–56.CrossRefPubMed
26.
go back to reference Latter S, Blenkinsopp A. Non-medical prescribing: current and future contribution of pharmacists and nurses. Int J Pharm Pract. 2011;19:381–2.CrossRefPubMed Latter S, Blenkinsopp A. Non-medical prescribing: current and future contribution of pharmacists and nurses. Int J Pharm Pract. 2011;19:381–2.CrossRefPubMed
28.
go back to reference Weeks GR, Ciabotti L, Gorman E, Abbott L, Marriott JL, George J. Can a redesign of emergency pharmacist roles improve medication management? A prospective study in three Australian hospitals. Res Social Adm Pharm. 2014;10:679–92.CrossRefPubMed Weeks GR, Ciabotti L, Gorman E, Abbott L, Marriott JL, George J. Can a redesign of emergency pharmacist roles improve medication management? A prospective study in three Australian hospitals. Res Social Adm Pharm. 2014;10:679–92.CrossRefPubMed
29.
go back to reference Rosenthal MM, Houle SK, Eberhart G, Tsuyuki RT. Prescribing by pharmacists in Alberta and its relation to culture and personality traits. Res Social Adm Pharm. 2015;11:401–11.CrossRefPubMed Rosenthal MM, Houle SK, Eberhart G, Tsuyuki RT. Prescribing by pharmacists in Alberta and its relation to culture and personality traits. Res Social Adm Pharm. 2015;11:401–11.CrossRefPubMed
31.
go back to reference Buckley P, Grime J, Blenkinsopp A. Inter-and intra-professional perspectives on non-medical prescribing in an NHS trust. Pharm J. 2006;277:394–8. Buckley P, Grime J, Blenkinsopp A. Inter-and intra-professional perspectives on non-medical prescribing in an NHS trust. Pharm J. 2006;277:394–8.
33.
go back to reference Rosenthal M, Austin Z, Tsuyuki RT. Are pharmacists the ultimate barrier to pharmacy practice change? Can Pharm J. 2010;143:37–42.CrossRef Rosenthal M, Austin Z, Tsuyuki RT. Are pharmacists the ultimate barrier to pharmacy practice change? Can Pharm J. 2010;143:37–42.CrossRef
34.
go back to reference Bourne RS, Whiting P, Brown LS, Borthwick M. Pharmacist independent prescribing in critical care: results of a national questionnaire to establish the 2014 UK position. Int J Pharm Pract. 2015;. doi:10.1111/ijpp.12219.PubMed Bourne RS, Whiting P, Brown LS, Borthwick M. Pharmacist independent prescribing in critical care: results of a national questionnaire to establish the 2014 UK position. Int J Pharm Pract. 2015;. doi:10.​1111/​ijpp.​12219.PubMed
36.
go back to reference Tonna A, McCaig D, Diack L, West B, Stewart D. Development of consensus guidance to facilitate service redesign around pharmacist prescribing in UK hospital practice. Int J Clin Pharm. 2014;36:1069–76.CrossRefPubMed Tonna A, McCaig D, Diack L, West B, Stewart D. Development of consensus guidance to facilitate service redesign around pharmacist prescribing in UK hospital practice. Int J Clin Pharm. 2014;36:1069–76.CrossRefPubMed
Metadata
Title
Pharmacist independent prescribing in secondary care: opportunities and challenges
Authors
Richard S. Bourne
Wasim Baqir
Raliat Onatade
Publication date
01-02-2016
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 1/2016
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0226-9

Other articles of this Issue 1/2016

International Journal of Clinical Pharmacy 1/2016 Go to the issue